Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation
暂无分享,去创建一个
N. Blüthgen | C. Loddenkemper | M. Labopin | D. Niederwieser | Johannes Meisig | C. Romagnani | C. Gentilini | Monica Killig | L. Uharek | C. Pfrepper | N. Basara | B. Friedrichs
[1] C. Romagnani,et al. Signatures of Human NK Cell Development and Terminal Differentiation , 2013, Front. Immunol..
[2] R. Handgretinger,et al. Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. , 2013, Cytotherapy.
[3] P. Ljungman. CMV: a warrior against leukemia? , 2013, Blood.
[4] B. Sandmaier,et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. , 2013, Blood.
[5] L. Moretta,et al. Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[6] J. Trowsdale,et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. , 2013, Blood.
[7] A. Gratwohl,et al. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers , 2013, Bone Marrow Transplantation.
[8] Jeffrey S. Miller,et al. Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen , 2012, The Journal of Immunology.
[9] A. Velardi. Natural killer cell alloreactivity 10 years later , 2012, Current opinion in hematology.
[10] R. Handgretinger,et al. Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation , 2012, Annals of the New York Academy of Sciences.
[11] L. Lanier,et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. , 2012, Blood.
[12] T. Asselah,et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self‐specific KIRs in chronic hepatitis patients , 2012, European journal of immunology.
[13] F. Locatelli,et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? , 2012, Blood.
[14] H. Liao,et al. G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT , 2012, Bone Marrow Transplantation.
[15] M. Baccarani,et al. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. , 2011, Blood.
[16] P. J. Norris,et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.
[17] F. Locatelli,et al. Human NK receptors: From the molecules to the therapy of high risk leukemias , 2011, FEBS letters.
[18] H. Ljunggren,et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. , 2010, Blood.
[19] H. Pircher,et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.
[20] A. Thiel,et al. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. , 2010, Blood.
[21] P. Debré,et al. NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs , 2010, PloS one.
[22] C. Pui,et al. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Caligiuri,et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. , 2010, Blood.
[24] L. Xu,et al. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors , 2009, Bone Marrow Transplantation.
[25] K. Hsu,et al. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. , 2009, Blood.
[26] M. Martinetti,et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. , 2009, Blood.
[27] Arnon Nagler,et al. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. , 2008, Blood.
[28] M. Sormani,et al. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. , 2008, Blood.
[29] T. Kuijpers,et al. Human NK cells can control CMV infection in the absence of T cells. , 2008, Blood.
[30] L. Kanz,et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. , 2008, Blood cells, molecules & diseases.
[31] E. Thiel,et al. The type of ATG matters -- natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius. , 2007, Transplant immunology.
[32] F. Aversa,et al. Competing risk analysis using R: an easy guide for clinicians , 2007, Bone Marrow Transplantation.
[33] S. Gasser,et al. Activation and self‐tolerance of natural killer cells , 2006, Immunological reviews.
[34] C. Mecucci,et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] P. Debré,et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. , 2005, Blood.
[36] C. Le,et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. , 2005, Blood.
[37] E. Thiel,et al. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets , 2005, Leukemia.
[38] E. Lanino,et al. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). , 2005, Blood.
[39] Chi-kong Li,et al. Elevated Serum Interleukin-15 Level in Acute Graft-Versus-Host Disease After Hematopoietic Cell Transplantation , 2003, Journal of pediatric hematology/oncology.
[40] D. Ligeiro,et al. Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[41] M. Caligiuri,et al. The biology of human natural killer-cell subsets. , 2001, Trends in immunology.
[42] T. Okamura,et al. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease , 2001, Bone Marrow Transplantation.
[43] H. Lazarus,et al. Genetically haploidentical stem cell transplantation for acute leukemia , 2001, Bone Marrow Transplantation.
[44] A. Tosti,et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.
[45] M. Minegishi,et al. Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children. , 1998, International journal of hematology.
[46] P. Ljungman. Immune reconstitution and viral infections after stem cell transplantation. , 1998, Bone marrow transplantation.
[47] F. Prósper,et al. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. , 1997, Blood.
[48] A. Barrett,et al. 10 Graft-versus-leukaemia , 1997 .
[49] M. Oudshoorn,et al. HLA gene haplotype frequencies in bone marrow donors worldwide registries. , 1997, Human immunology.
[50] F. Aversa,et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. , 1994, Blood.